Clinical presentation, case management and outcomes for the first 32 COVID-19 patients in Nigeria

Abstract

Introduction Success in curtailing the pandemic coronavirus disease (COVID-19) depends largely on a sound understanding of the epidemiologic and clinical profile of cases in a population as well as the case management approach. This study documents the presenting characteristics, treatment modalities and outcomes of the first 32 COVID-19 patients in Nigeria. Methods This retrospective study used medical records of the first 32 patients admitted and discharged from the Mainland Hospital, Lagos State, southwest Nigeria between February 27 and April 6, 2020. The outcomes of interest were death, promptness of admission process and duration of hospitalization. Results The mean age of the patients was 38.1 years (SD: 15.5) and 66% were male. Three-quarters (75%) of the patients presented in moderately severe condition while 16% were asymptomatic. The most common presenting symptoms were fever (59%) and dry cough (44%). The mean time between a positive test result and admission was 1.63 days (SD: 1.31). Almost all (97%) the patients were treated with lopinavir-ritonavir with no recorded death. The median duration of hospital stay was 12 days (IQR: 9-13.5). Conclusion In this preliminary analysis of the first COVID-19 cases in Nigeria, clinical presentation was mild to moderate with no mortality. Processes to improve promptness of admission and reduce hospital stay are required to enhance the response to COVID-19 in Nigeria.

Epidemiology of COVID-19 and Predictors of Outcome in Nigeria: A Single-Center Study

“…The hospital is a tertiary health facility fairly well-equipped compared with most COVID-19 treatment centers in Nigeria. Despite being limited by bed spaces (15) for COVID-19, it has two functioning ventilators with the capacity to carry out mechanical ventilation and a dedicated hemodialysis machine for COVID-19.…”

“…14 Despite the increasing available literature on COVID-19, very few publications have emerged from Africa inclusive of Nigeria. 15,16 Besides, curtailing the COVID-19 pandemic in middle-and low-income countries requires understanding the clinical presentations, laboratory characteristics, and factors associated with poor outcomes in patients with COVID-19. We hypothesized that predictors of outcomes of COVID-19 in Nigeria may differ from those in other countries.…”

COVID‐19 and obstetric practice: A critical review of the Nigerian situation

“…It is also pertinent to note that the available isolation centers in the country are not equipped for the care of the obstetric patient, both in terms of facilities and manpower. Ventilators, which may be required to support the life of infected patients, are very scarce in Nigeria, as in other African countries 24 …”

Morbidity and mortality outcomes of COVID-19 patients with and without hypertension in Lagos, Nigeria: A retrospective cohort study

“…The patients categorized as critical cases were those in respiratory failure. [18] History of hypertension The data on comorbidities including hypertension was based the patient's report of previous diagnosis prior to the infection with SARS-CoV-2. Those who required antihypertensive medication during hospitalization with no prior prescription were treated with antihypertensives, while those who had been on medications prior to admission, were treated with their usual prescribed medication.…”